Skip to main content
Trending storyContinuously updated

Samplix raises €25M first close of €30M round

1 reports1 report sources3 hours agoUpdate

Get up to speed on this story

AI Summary

Danish biotech Samplix has announced a €25 million first close of a financing round, part of a round targeting €30 million total that remains open to additional investors. The company develops droplet microfluidics technology for functional single-cell analysis. Only €3 million of the first close is new capital; the other €22 million comes from shareholder convertible bonds.

AI-generated from reports · 3 hours agoUpdate

Latest updatesOct 28 14:31
Danish biotech Samplix raises €25M first close to scale antibody discovery

Report timeline

Follow the reports to understand different sides of the story.

Oct 28
  1. EU-StartupsTop Deals
    Danish biotech Samplix raises €25M first close to scale antibody discovery

    Samplix, a Danish biotech company, announced a €25 million first close of its financing round.

Trend for this story

Comparable range current
9
Comparable range peak
10Oct 28 15:00
Change in the last 24 hours
–

Trends only compare the same entities observed consistently and completely, so the scope may be smaller than the current trending statistics. Move the pointer or click the chart to view hourly trending; use the left and right arrow keys on a keyboard to switch.

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing